Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: AMRI | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: AMRI

Contract revenue up 52% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AMRI
 
4Q Revenues: $126.4 million (+46%)
 
4Q Earnings: $1.8 million (loss of $1.9 million 4Q14)
 
FY Revenues: $402.3 million (+45%)
 
FY Loss: $2.3 million (loss of $3.3 million FY14)
 
Comments: Contract revenue for the quarter was $123.0 million, up 52%. Margins benefited from recent acquisitions, product mix within the Drug Product segment and the impact of cost reduction initiatives and facility optimization activities. Royalty revenue in the quarter was $3.4 million, down 43% due to lower royalties on Allegra products, which have ended based on the patent expirations.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters